Breast Cancer Biomarkers

The Estrogen Receptor + Progesterone Receptor + HER-2/neu test is a comprehensive diagnostic tool used to evaluate breast cancer tumors for the presence of three critical biomarkers: estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor 2 (HER-2/neu).

Sample Type : Paraffin Embedded Block/Charged Slides
Methodology : Immunohistochemical
TAT : 7 Days